期刊文献+

ICU肺部感染并鲍曼不动杆菌分离阳性患者临床特征及预后 被引量:5

Anaiysis of Clinical Manifestations and Risk Factors of Mortality due to Acinetobacter Baumannii Positive Pulmonary Infection in ICU
下载PDF
导出
摘要 目的通过分析下呼吸道分泌物中分离出鲍曼不动杆菌的肺部感染患者其临床特征、对常用抗菌药物的耐药性及预后,探讨其死亡相关的危险因素。方法回顾性分析2012年6月~2017年6月郑州大学第五附属医院ICU下呼吸道分泌物分离出鲍曼不动杆菌的肺部感染患者其临床资料,包括人口学资料、基础疾病、细菌耐药性、发病时APACHEⅡ评分、抗菌药物治疗方案;依据患者28天预后结果分为死亡组和存活组;通过单因素分析和多因素Logistic回归分析死亡相关的危险因素。结果本研究共纳入98例患者,共分离出110株鲍曼不动杆菌,对头孢哌酮舒巴坦耐药率较低(17株);对美罗培南(88株)、亚胺培南(80株)的耐药率较高。28天病死率54.1%;死亡危险因素分析结果显示:合并冠心病(OR=38.3,95%CI:1.81~720.10,P=0.019)、高APACHEⅡ评分(OR=3.47,95%CI:1.30~12.81,P=0.043)、高降钙素原水平(OR=2.78,95%CI:1.30~7.02,P=0.023)、APTT延长(OR=1.32,95%CI:1.03~1.71,P=0.037)为患者28天死亡的独立危险因素;APACHEⅡ评分与死亡组患者鲍曼不动杆菌培养阳性后的生存时间呈负相关(r=-0.601,P=0.000);是否应用对鲍曼不动杆菌敏感的抗菌药物未明确影响预后。结论肺部感染并鲍曼不动杆菌分离阳性患者合并冠心病、高APACHEⅡ评分、高降钙素原水平、APTT延长为患者28天死亡的独立危险因素;尤其是合并冠心病及基础疾病的严重程度决定患者的预后。 Objective To analyze the clinical manifestations,bacterial resistance to antibiotics and risk factors of mortality in pneumonia patients with Acinetobacter baumannii( AB) positive in respiratory secretions. Methods Clinical datas of pneumonia patients with AB positive in respiratory secretions in ICU from June 2012 to June 2017 were analyzed. According to the 28 day survival after diagnosis,the patients were divided into death group and survival group. Univariate and multivariate Logistic analysis were used to examine the risk factors of AB positive patients. Results This study included 98 patients. The 28 day mortality was 54. 1%. The independent risk factors of mortality were: merge coronary heart disease( OR = 38. 3,95% CI: 1. 81-720. 10,P = 0. 019),high APACHEⅡscore( OR = 3. 47,95% CI: 1. 30-12. 81,P = 0. 043),prolonged APTT( OR = 1. 32,95% CI: 1. 03-1. 71,P = 0. 037),high levels of PCT( OR = 2. 78,95% CI: 1. 30-7. 02,P = 0. 023). APACHEⅡscores and patients died from AB culture positive time was significantly negative correlation,r =-0. 601,P = 0. 000. Whether the application of antibiotics for AB was not clearly affected by the prognosis. Conclusion Merge coronary heart disease,high APACHEⅡscore,prolonged APTT,high levels of PCT are independent risk factors for AB culture positive patients. In particular,merge coronary heart disease and the severity of the underlying disease determine the patient's prognosis.
作者 张娆娆 徐瑞华 石宗华 Zhang Raorao;Xu Ruihua;Shi Zonghua(Intensive Care Unit,The Fifth Affiliated Hospital of Zhengzhou University,Henan 450052,China)
出处 《医学研究杂志》 2018年第6期125-129,共5页 Journal of Medical Research
关键词 重症医学科 鲍曼不动杆菌 预后因素 ICU Acinetobacter baumannii Prognosis
  • 相关文献

参考文献7

二级参考文献82

  • 1周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:238
  • 2陈琳,陈杖榴,刘健华.氨基糖苷类药物耐药新机制——16S rRNA甲基化酶的研究进展[J].中国兽医科学,2006,36(11):935-939. 被引量:14
  • 3Ylipalosaari P, Ala - Kokko TI, Laurila J, et al. Epidemiology of intensive care unit (ICU) -acquired infections in a 14 month pro- spective cohort study in a single mixed Scandinavian University Hos- pital ICU [J]. Acta Anaesthesiol Scand, 2006; 50:1192 - 1197.
  • 4Fridkin SK, Edwards JE, Tenover FC, et al. For the Intensive Care Antimicrobial Resistance Epidemiology (ICARE) project and the National Nosocomial Infections Surveillance (NNIS) system hospi- tals. Antimicrobial resistance prevalence rates in hospital antibio- grams reflect prevalence rates among pathogens associated with hos- pital - acquired infections [J]. Clin Infect DIS, 2001 ; 33:324 - 330.
  • 5Gordon NC, Wareham DW. A review of clinical and microbiological outcomes following treatment of infections involving multidrug - re- sistant Acinetobacter baumannii with tigecycline [ J ]. J Antimicrob Chemother, 2009 ; 63:775 - 780.
  • 6Bassetti M. Ginocchio F, Mikulska M. New treatment options a-gainst gram-negative organisms[J]. Crit Care,2011,15(2): 215.
  • 7Bou G, Cervero G, Dominguez MA, et al. Characterization of anosocomial outbreak caused by a multiresistant Acinetobacterbaumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely tothe presence of beta-lactamases [ J]. J Clin Microbiol, 2000,38(9):3299-3305.
  • 8Donald HM,Scaife W, Amyes SG,et al. Sequence analysis of ARI-l,a novel OX A beta-lactamase, responsible for imipenem resist-ance in Acinetobacter baumannii 6B92 [J]. Antimicrob AgentsChemother,2000,44(1) : 196-199.
  • 9Lu P L,Doumith M,Livermore DM,et al. Diversity of carbapenemresistance mechanisms in Acinetobacter baumannii from a Taiwanhospital: spread of plasmid-borne OXA-72 carbapenemase[J]. JAntimicrob Chemother,2009 ,63(4) : 641-647.
  • 10Limansky AS,Mussi MA, Viale AM. Loss of a 29-kilodalton outermembrane protein in Acinetobacter baumannii is associated withimipenem resistance [J]. J Clin Microbiol, 2002,40 (12): 4776-4778.

共引文献1139

同被引文献38

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部